(Q37598897)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19761370%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

review article

1 reference

title

Drug-induced liver injury: insights from genetic studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19761370%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19761370%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Mercedes Robles

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19761370%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Eugenia Ulzurrun

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19761370%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

M Isabel Lucena

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19761370%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

language of work or name

1 reference

1 September 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19761370%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19761370%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19761370%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19761370%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

1467-1487

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19761370%20AND%20SRC:MED&resulttype=core&format=json

Hepatotoxicity in drug development: detection, significance and solutions

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Acute Liver Failure in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Policy developments in regulatory approval

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Clinical perspectives on xenobiotic-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

The role of metabolic activation in drug-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Incidence of drug-induced hepatic injuries: a French population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Incidence of drug-induced liver injury in medical inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

The danger hypothesis applied to idiosyncratic drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Idiosyncratic drug reactions: current understanding

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Acute and clinically relevant drug-induced liver injury: a population based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Mitochondrial abnormalities--a link to idiosyncratic drug hepatotoxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Idiosyncratic drug hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Acute liver injury associated with the use of ebrotidine, a new H2-receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Trovafloxacin-induced acute hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Antidepressant-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Bentazepam-associated chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Mitochondria in steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Withdrawal of life support, altruistic suicide, fratricidal killing and euthanasia by lymphocytes: different forms of drug-induced hepatic apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Liver biology and pathobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Sensitivity of liver injury in heterozygous Sod2 knockout mice treated with troglitazone or acetaminophen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Candidate gene case-control association studies: advantages and potential pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Searching for genetic determinants in the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Drug-induced hepatotoxicity: 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Genetic factors in the predisposition to drug-induced hypersensitivity reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Keynote address: man, mice, microsomes, metabolites, and mathematics 40 years after the revolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Are chemically reactive metabolites responsible for adverse reactions to drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Role of metabolism in drug-induced idiosyncratic hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Induction of phase I, II and III drug metabolism/transport by xenobiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Causality assessment in drug-induced hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Epidemiology and individual susceptibility to adverse drug reactions affecting the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Hepatotoxicity of herbal remedies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Possible association between poor metabolism of mephenytoin and hepatotoxicity caused by Atrium, a fixed combination preparation containing phenobarbital, febarbamate and difebarbamate

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Clinical consequences of cytochrome P450 2C9 polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Genetic predisposition to drug-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Leflunomide-induced acute hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Is diclofenac a valuable CYP2C9 probe in humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Relationship of polymorphism in CYP2C9 to genetic susceptibility to diclofenac-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

The role of CYP2C9 genotype in the metabolism of diclofenac in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Influence of CYP2C9 polymorphisms on the pharmacokinetics and cholesterol-lowering activity of (-)-3S,5R-fluvastatin and (+)-3R,5S-fluvastatin in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Genetic polymorphisms of CYP2C9 and CYP2C19 in the Beninese and Belgian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Determination of debrisoquine and 4-hydroxydebrisoquine by high-performance liquid chromatography: application to the evaluation of CYP2D6 genotype and debrisoquine metabolic ratio relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Impaired oxidation of debrisoquine in patients with perhexiline liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

A proposed mechanism for chlorpromazine jaundice--defective hepatic sulphoxidation combined with rapid hydroxylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Chemistry, Pharmacology, Toxicology, and Hepatic Metabolism of Designer Drugs of the Amphetamine (Ecstasy), Piperazine, and Pyrrolidinophenone Types

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Metabolism of the newer antidepressants. An overview of the pharmacological and pharmacokinetic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Hepatic injury caused by mianserin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Fatal hepatic necrosis associated with trazodone and neuroleptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Assignment of the human cytochrome P-450 nifedipine oxidase gene (CYP3A4) to chromosome 7 at band q22.1 by fluorescence in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Pharmacogenetic determinants of human liver microsomal alfentanil metabolism and the role of cytochrome P450 3A5.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Regulation of CYP3A4 by the bile acid receptor FXR: evidence for functional binding sites in the CYP3A4 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Indirect cytotoxicity of flucloxacillin toward human biliary epithelium via metabolite formation in hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Simvastatin-amiodarone interaction resulting in rhabdomyolysis, azotemia, and possible hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Idiosyncratic drug reactions: the reactive metabolite syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

21 January 2018

Glutathione transferases

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

The potent protective effect of wild ginseng (Panax ginseng C.A. Meyer) against benzo[alpha]pyrene-induced toxicity through metabolic regulation of CYP1A1 and GSTs.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase Pi.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Characterization of resistance to bromobenzene-induced hepatotoxicity by microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Selective mitochondrial glutathione depletion by ethanol enhances acetaminophen toxicity in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Role of glutathione S-transferases A1-1, M1-1, and P1-1 in the detoxification of 2-phenylpropenal, a reactive felbamate metabolite.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

A study to survey susceptible genetic factors responsible for troglitazone‐associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Glutathione S-transferase mu genotype (GSTM1*0) in Alzheimer's patients with tacrine transaminitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 'null' mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Drug-induced immunotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Autoantibodies against CYP2D6 and other drug-metabolizing enzymes in autoimmune hepatitis type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Molecular mimicry in halothane hepatitis: biochemical and structural characterization of lipoylated autoantigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Analysis of the intron-exon organization of the human multidrug-resistance protein gene (MRP) and alternative splicing of its mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Exon-intron organization of the human multidrug-resistance protein 2 (MRP2) gene mutated in Dubin-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport-deficient mutant hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

21 January 2018

Bile salt transporters

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Enterohepatic bile salt transporters in normal physiology and liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Sulindac is excreted into bile by a canalicular bile salt pump and undergoes a cholehepatic circulation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Identification of a reactive metabolite of terbinafine: insights into terbinafine-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Mrp2-deficiency in the rat impairs biliary and intestinal excretion and influences metabolism and disposition of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

MRP2 haplotypes confer differential susceptibility to toxic liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Molecular pathogenesis of cholestasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Interindividual variability in catalytic activity and immunoreactivity of three major human liver cytochrome P450 isozymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

The metabolism of diclofenac--enzymology and toxicology perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Analysis of IL-10, IL-4 and TNF-alpha polymorphisms in drug-induced liver injury (DILI) and its outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Molecular and genetic association of interleukin-6 in tacrine-induced hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

HLA association of amoxicillin-clavulanate--induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Efficiency and power in genetic association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Genetic epidemiology and public health: hope, hype, and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

Pharmacogenetics and drug development: the path to safer and more effective drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

What makes a good genetic association study?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

What Genome-wide Association Studies Can Do for Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.111

21 January 2018

Identifiers

DOI

10.2217/PGS.09.111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19761370%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference